Ratings by Canaccord (Gary Nachman)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/22/2026 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2026 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2026 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 4/20/2026 | Abbvie | ABBV | New Coverage | Buy (N/A) |
208.38 (253.30) |
21.56% | Details | |
| 4/20/2026 | Amgen | AMGN | New Coverage | Buy (N/A) |
355.30 (366.05) |
3.03% | Details |
